Sec. 3071. SILVIO O. CONTE SENIOR BIOMEDICAL RESEARCH AND BIOMEDICAL PRODUCT ASSESSMENT SERVICE
698 words·~3 min read·
/statute-compilations/comps-13005/sec-3071A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 3071 SILVIO O. CONTE SENIOR BIOMEDICAL RESEARCH AND BIOMEDICAL PRODUCT ASSESSMENT SERVICE ###
(a)Hiring and Retention Authority Section 228 of the Public Health Service Act (42 U.S.C. 237) is amended— ####
(1)in the section heading, by inserting “and biomedical product assessment” after “research”; ####
(2)in subsection (a)— #####
(A)in paragraph (1), by striking “Silvio O. Conte Senior Biomedical Research Service, not to exceed 500 members” and inserting “Silvio O. Conte Senior Biomedical Research and Biomedical Product Assessment Service (in this section referred to as the ‘Service’), not to exceed 2,000 members, the purpose of which is to recruit and retain outstanding and qualified scientific and technical experts in the fields of biomedical research, clinical research evaluation, and biomedical product assessment”; #####
(B)by amending paragraph
(2)to read as follows: > > #### “(2) > > The authority established in paragraph
(1)may not be construed to require the Secretary to reduce the number of employees serving under any other employment system in order to offset the number of members serving in the Service.” > ; and #####
(C)by adding at the end the following: > > #### “(3) > > The Secretary shall assign experts under this section to agencies within the Department of Health and Human Services taking into account the need for the expertise of such expert.” > ; ####
(3)in subsection (b)— #####
(A)in the matter preceding paragraph (1), by striking “or clinical research evaluation” and inserting “, clinical research evaluation, or biomedical product assessment”; and #####
(B)in paragraph (1), by inserting “or a doctoral or master’s level degree in engineering, bioinformatics, or a related or emerging field,” after the comma; ####
(4)in subsection (d)(2), by striking “and shall not exceed the rate payable for level I of the Executive Schedule unless approved by the President under section 5377(d)(2) of title 5, United States Code” and inserting “and shall not exceed the amount of annual compensation (excluding expenses) specified in section 102 of title 3, United States Code”; ####
(5)by striking subsection (e); and ####
(6)by redesignating subsections
(f)and
(g)as subsections
(e)and (f), respectively. ###
(b)GAO Study ####
(1)In general The Comptroller General of the United States shall conduct a study of the effectiveness of the amendments to section 228 of the Public Health Service Act (42 U.S.C. 237) made by subsection
(a)and the impact of such amendments, if any, on all agencies or departments of the Department of Health and Human Services, and, not later than 4 years after the date of enactment of this Act, shall submit a report based on such study to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives. ####
(2)Content of study and report The study and report under paragraph
(1)shall include an examination of the extent to which recruitment and retention of outstanding and qualified scientific, medical, or technical experts in the fields of biomedical research, clinical research evaluation, and biomedical product assessment have improved or otherwise have been affected by the amendments to section 228 of the Public Health Service Act (42 U.S.C. 237) made by subsection (a), including by determining, during the period between the date of enactment of this Act and the completion of the study— #####
(A)the total number of members recruited and retained under the Senior Biomedical Research and Biomedical Product Assessment Service under such section 228, and the effect of increasing the number of members eligible for such Service; #####
(B)the number of members of such Senior Biomedical Research and Biomedical Product Assessment Service hired with a doctoral level degree in biomedicine or a related field, and the number of such members hired with a doctoral or master’s level degree in engineering, bioinformatics, or a related or emerging field; and #####
(C)the number of Senior Biomedical Research and Biomedical Product Assessment Service members that have been hired by each agency or department of the Department of Health and Human Services, and how such Department assigns such members to each agency or department.
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 3071
SILVIO O. CONTE SENIOR BIOMEDICAL RESEARCH AND BIOMEDICAL PRODUCT ASSESSMENT SERVICE
Cites 1Cited by 0 across 0 sources